Company Explorer

Active Filters
City
South San Francisco
Remove ✕
Sector
Healthcare
Remove ✕
Clear All
Top Funding Lists
United States $2622691M
China $575047M
United Kingdom $382021M
India $195598M
Germany $111860M
France $106081M
Canada $98297M
Switzerland $67376M
Singapore $65216M
Australia $61917M
South Korea $60905M
Japan $59054M
Sweden $59013M
Netherlands $48437M
Saudi Arabia $47207M
Israel $45380M
Brazil $43478M
Spain $42624M
Italy $41208M
Ireland $31538M
Indonesia $28750M
Denmark $22131M
Hong Kong $19873M
Mexico $18642M
Turkey $17392M
Norway $16504M
Bermuda $14157M
Belgium $13584M
South Africa $13197M
Philippines $11749M
Nigeria $10624M
Finland $10392M
Malaysia $8791M
Colombia $8584M
Chile $8082M
Poland $7499M
Kenya $7076M
Luxembourg $6530M
Egypt $6335M
Austria $5717M
Taiwan $5558M
Portugal $4785M
Peru $4544M
Thailand $4295M
Romania $4123M
Vietnam $4001M
New Zealand $3961M
Pakistan $3306M
New York $255477M
San Francisco $228382M
London $219334M
Beijing $206805M
Shanghai $89221M
Denver $65232M
Boston $61326M
Mumbai $59088M
Palo Alto $57515M
San Diego $56173M
Chicago $50672M
Tokyo $48222M
Seoul $48079M
Austin $47758M
Paris $46676M
Cambridge $45402M
Dallas $45373M
Berlin $44855M
San Jose $44429M
Bengaluru $43757M
Mountain View $43526M
Stockholm $43160M
Riyadh $40248M
Houston $36779M
Shenzhen $36590M
Los Angeles $35888M
Singapore $34000M
Atlanta $33359M
Santa Monica $32612M
Dubai $31061M
Seattle $30896M
Hangzhou $30582M
Irvine $29260M
Sao Paulo $29213M
Redwood City $28616M
Santa Clara $27216M
Toronto $26562M
Plano $25670M
San Mateo $25657M
Miami $23004M
Jakarta $21889M
Milan $20729M
Madrid $20386M
Guangzhou $19455M
Menlo Park $19292M
Adelaide $19115M
Tel Aviv $18720M
Sunnyvale $18619M
Internet / China $161099M
Finance / China $40071M
Finance / India $18459M
Results (141 companies)
Lyell
Lyell is a clinical-stage biotechnology company focused on developing T-cell therapies for cancer treatment. The company
IPO 📍 United States Healthcare
ArsenalBio
Arsenal Biosciences specializes in programmable cell therapies within the biotechnology sector. The company focuses on d
Alive 📍 United States Healthcare
Alumis
Alumis is involved in the development of therapies for immune-mediated diseases within the biopharmaceutical industry. T
IPO 📍 United States Healthcare
Stemcentrx
Stemcentrx develops novel cancer therapies and diagnostics. It treats cancers by killing cancer stem cells, or cells tho
Acquired 📍 United States Healthcare
Maze Therapeutics
Maze Therapeutics develops medicines for diseases with unmet medical needs. The company utilizes human genetics, variant
IPO 📍 United States Healthcare
Allogene Therapeutics
Allogene Therapeutics is a clinical-stage biotechnology company focused on the development of allogeneic chimeric antige
IPO 📍 United States Healthcare
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a biopharmaceutical company involved in the discovery and development of medicines for various
Alive 📍 United States Healthcare
Sonoma Biotherapeutics
Sonoma Biotherapeutics focuses on developing living cell therapies for the immune system within the biotherapeutics sect
Alive 📍 United States Healthcare
Cellares
Cellares is an integrated development and manufacturing organization (IDMO) that specializes in the manufacturing of cel
Alive 📍 United States Healthcare
Denali Therapeutics
Denali Therapeutics is a biotechnology company focused on the discovery and development of therapeutics for neurodegener
IPO 📍 United States Healthcare
Pionyr Immunotherapeutics
Pionyr Immunotherapeutics is a clinical-stage biotechnology company. It develops cancer immunotherapies that target the
Acquired 📍 United States Healthcare
Tizona Therapeutics
Tizona Therapeutics offers the development of immunotherapies for cancer treatment. It offers creating therapies that mo
Alive 📍 United States Healthcare
Neurona Therapeutics
Neurona Therapeutics focuses on developing cell therapies for the nervous system within the healthcare sector. The compa
Alive 📍 United States Healthcare
Twist Bioscience
Twist Bioscience is a synthetic biology company that produces synthetic DNA. The company offers products including gene
IPO 📍 United States Healthcare
Portola Pharmaceuticals
Portola is a biopharmaceutical company focused on the development and commercialization of therapeutics in the areas of
Acquired 📍 United States Healthcare
Septerna
Septerna focuses on G protein-coupled receptor (GPCR) drug discovery. The company uses its native complex platform to di
IPO 📍 United States Healthcare
Tenaya Therapeutics
Tenaya Therapeutics (NASDAQ: TNYA) is a clinical-stage biotechnology company that focuses on developing curative therapi
IPO 📍 United States Healthcare
Intervenn
Intervenn decodes the glycoproteome to provide biological insights within the healthcare sector. The company has a techn
Alive 📍 United States Healthcare
DICE Therapeutics
DiCE Therapeutics (NASDAQ: DICE) is a clinical-stage biopharmaceutical company. It designs and develops small-molecule c
Acquired 📍 United States Healthcare
CytoVale
CytoVale is a medical diagnostics company that focuses on the diagnosis of fast-moving and immune-mediated diseases with
Alive 📍 United States Healthcare